239 related articles for article (PubMed ID: 31708414)
21. Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.
Kodet O; Dvořánková B; Bendlová B; Sýkorová V; Krajsová I; Štork J; Kučera J; Szabo P; Strnad H; Kolář M; Vlček Č; Smetana K; Lacina L
Int J Mol Med; 2018 May; 41(5):2687-2703. PubMed ID: 29393387
[TBL] [Abstract][Full Text] [Related]
22. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
23. Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.
Zhang Q; Yang J; Bai J; Ren J
Cancer Sci; 2018 Apr; 109(4):944-955. PubMed ID: 29383798
[TBL] [Abstract][Full Text] [Related]
24. T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting.
Hanley CJ; Thomas GJ
Br J Cancer; 2020 Oct; 123(9):1353-1355. PubMed ID: 32830198
[TBL] [Abstract][Full Text] [Related]
25. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
26. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
27. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
28. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
Chandra Jena B; Sarkar S; Rout L; Mandal M
Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
[TBL] [Abstract][Full Text] [Related]
29. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Guo J; Zeng H; Chen Y
Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
[TBL] [Abstract][Full Text] [Related]
30. Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.
Hussain A; Voisin V; Poon S; Karamboulas C; Bui NHB; Meens J; Dmytryshyn J; Ho VW; Tang KH; Paterson J; Clarke BA; Bernardini MQ; Bader GD; Neel BG; Ailles LE
J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32434219
[TBL] [Abstract][Full Text] [Related]
31. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
[TBL] [Abstract][Full Text] [Related]
32. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
33. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
34. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
[TBL] [Abstract][Full Text] [Related]
35. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
Jung JG; Le A
Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
[TBL] [Abstract][Full Text] [Related]
36. BAG3 in Tumor Resistance to Therapy.
De Marco M; Turco MC; Marzullo L
Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
38. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
[TBL] [Abstract][Full Text] [Related]
40. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
